Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Vaezi

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Alimentary Pharmacology & Therapeutics|July 27, 2021
Systematic review: duodenogastroesophageal (biliary) reflux prevalence, symptoms, oesophageal lesions and treatmentChamara Basnayake, Annelies Geeraerts, Ans Pauwels, et al.
Gastroenterology|January 10, 2012
Pediatric patients with dyspepsia have chronic symptoms, anxiety, and lower quality of life as adolescents and adultsSara W Rippel, Sari Acra, Hernán Correa, et al.
Journal of Clinical Gastroenterology|November 12, 2025
Long-Term Reflux Outcomes-A Pragmatic Study of Mucosal Integrity TestingDhweeja Dasarathy, Ahmed Samy, Sara Treat, et al.
Journal of Voice : Official Journal of the Voice Foundation|May 13, 2008
Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric refluxGregory J Wiener, Ross Tsukashima, Colleen Kelly, et al.
The American Journal of Gastroenterology|February 28, 2002
Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosaJohn R Goldblum, Joel E Richter, Michael Vaezi, et al.
Neurogastroenterology and Motility|June 30, 2021
Chicago Classification update (version 4.0): Technical review on diagnostic criteria for achalasiaAbraham Khan, Rena Yadlapati, Sutep Gonlachanvit, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2022
Validation of the Achalasia Patient-Reported Outcomes QuestionnaireJohn E Pandolfino, Dustin A Carlson, Josie McGarva, et al.
Alimentary Pharmacology & Therapeutics|September 26, 2023
Randomised clinical trial: Efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux diseaseRonnie Fass, Michael Vaezi, Prateek Sharma, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2025
Clinical Trial: Dose-Finding Study of Linaprazan Glurate, A Novel Potassium-Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive OesophagitisPrateek Sharma, Michael Vaezi, Peter Unge, et al.
Cells|February 23, 2024
Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic EsophagitisChandra Sekhar Yadavalli, Sathisha Upparahalli Venkateshaiah, Alok K Verma, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|July 27, 2021
Systematic review: duodenogastroesophageal (biliary) reflux prevalence, symptoms, oesophageal lesions and treatmentChamara Basnayake, Annelies Geeraerts, Ans Pauwels, et al.
Gastroenterology|January 10, 2012
Pediatric patients with dyspepsia have chronic symptoms, anxiety, and lower quality of life as adolescents and adultsSara W Rippel, Sari Acra, Hernán Correa, et al.
Journal of Clinical Gastroenterology|November 12, 2025
Long-Term Reflux Outcomes-A Pragmatic Study of Mucosal Integrity TestingDhweeja Dasarathy, Ahmed Samy, Sara Treat, et al.
Journal of Voice : Official Journal of the Voice Foundation|May 13, 2008
Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric refluxGregory J Wiener, Ross Tsukashima, Colleen Kelly, et al.
The American Journal of Gastroenterology|February 28, 2002
Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosaJohn R Goldblum, Joel E Richter, Michael Vaezi, et al.
Neurogastroenterology and Motility|June 30, 2021
Chicago Classification update (version 4.0): Technical review on diagnostic criteria for achalasiaAbraham Khan, Rena Yadlapati, Sutep Gonlachanvit, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2022
Validation of the Achalasia Patient-Reported Outcomes QuestionnaireJohn E Pandolfino, Dustin A Carlson, Josie McGarva, et al.
Alimentary Pharmacology & Therapeutics|September 26, 2023
Randomised clinical trial: Efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux diseaseRonnie Fass, Michael Vaezi, Prateek Sharma, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2025
Clinical Trial: Dose-Finding Study of Linaprazan Glurate, A Novel Potassium-Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive OesophagitisPrateek Sharma, Michael Vaezi, Peter Unge, et al.
Cells|February 23, 2024
Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic EsophagitisChandra Sekhar Yadavalli, Sathisha Upparahalli Venkateshaiah, Alok K Verma, et al.
Pageof 3